Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

Share Price is delayed by 15 minutes
Get Live Data
217.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 18.00 (8.654%)
Market Cap: £1.29b
KOS Live PriceLast checked at - London Stock Exchange

Intraday Kosmos Energy Share Chart

Director/PDMR Shareholding

13 Mar 2026 07:00

RNS Number : 4886W
Kosmos Energy Limited
13 March 2026
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

12 March 2026

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR

Date of transaction

No. of shares acquired

Andrew G. Inglis

10 March 2026

315,790

Neal D. Shah

10 March 2026

157,894

J. Michael Stice

10 March 2026

52,631

Adebayo O. Ogunlesi

10 March 2026

3,157,895

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.comMedia Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and CEO

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

315,790 shares purchased in an Underwritten Public Offering.

 

c)

Currency

USD

Price

1.90

Volume

315,790

Total

600,001.00

d)

Aggregated information 

Price

1.90

Volume

315,790

Total

600,001.00

e)

Date of the transactions

10 March 2026

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Neal D. Shah

b)

Position / status

Senior Vice President and CFO

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

157,894 shares purchased in an Underwritten Public Offering.

 

c)

Currency

USD

Price

1.90

Volume

157,894

Total

299,998.60

d)

Aggregated information 

Price

1.90

Volume

157,894

Total

299,998.60

e)

Date of the transactions

10 March 2026

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

J. Michael Stice

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

52,631 shares purchased in an Underwritten Public Offering.

 

c)

Currency

USD

Price

1.90

Volume

52,631

Total

99,998.90

d)

Aggregated information 

Price

1.90

Volume

52,631

Total

99,998.90

e)

Date of the transactions

10 March 2026

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Adebayo O. Ogunlesi

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

3,157,895 shares purchased in an Underwritten Public Offering.

 

c)

Currency

USD

Price

1.90

Volume

3,157,895

Total

6,000,000.50

d)

Aggregated information 

Price

1.90

Volume

3,157,895

Total

6,000,000.50

e)

Date of the transactions

10 March 2026

f)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFEFUEEMSEED
Date   Source Headline
16th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20204:38 pmRNSPrice Monitoring Extension
9th Nov 20207:00 amRNS3rd Quarter Results
14th Oct 20207:00 amRNSSuccessful Reserve Based Lending Re-determination
13th Oct 20207:00 amRNSKosmos Energy Announces Third Quarter Results Date
6th Oct 20204:35 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSClosing of $200 million Gulf of Mexico facility
9th Sep 20207:00 amRNSFarm Down of a Portfolio of Exploration Assets
3rd Sep 20207:00 amRNSConference Participation
26th Aug 20204:41 pmRNSSecond Price Monitoring Extn
26th Aug 20204:36 pmRNSPrice Monitoring Extension
25th Aug 20204:35 pmRNSPrice Monitoring Extension
19th Aug 20204:36 pmRNSPrice Monitoring Extension
12th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20204:35 pmRNSPrice Monitoring Extension
4th Aug 20204:36 pmRNSPrice Monitoring Extension
3rd Aug 20207:00 amRNS2nd Quarter Results
7th Jul 20207:00 amRNSSecond Quarter Results Date
3rd Jul 20207:00 amRNSProduction Prepayment Agreement
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSProduction Prepayment Agreement
23rd Jun 20204:35 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSResult of AGM
15th Jun 20204:40 pmRNSSecond Price Monitoring Extn
15th Jun 20204:35 pmRNSPrice Monitoring Extension
12th Jun 20204:36 pmRNSPrice Monitoring Extension
12th Jun 20207:00 amRNSDirector/PDMR Shareholding
5th Jun 20204:37 pmRNSPrice Monitoring Extension
27th May 20204:41 pmRNSSecond Price Monitoring Extn
27th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20204:35 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20204:41 pmRNSSecond Price Monitoring Extn
14th May 20204:36 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSPublication of Proxy Statement
11th May 20203:00 pmRNSChief Financial Officer succession
11th May 20207:00 amRNS1st Quarter Results
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:37 pmRNSPrice Monitoring Extension
23rd Apr 20204:42 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSFirst quarter results date
23rd Apr 20207:00 amRNSContinued Listing Standard Notice
20th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:36 pmRNSPrice Monitoring Extension
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20204:42 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.